BECN1 and ST Elevation Myocardial Infarction: Maintaining appropriate activation of autophagic flux and mitochondrial biogenesis by Tat-Beclin 1 or other agents may be used in future myocardial protection clinical trials in ST-elevation myocardial infarction patients.